The antiretroviral CCR5-inhibitor maraviroc effectively reverses HIV latency by phosphorylation of Nf-kappa B
DSpace/Manakin Repository
The antiretroviral CCR5-inhibitor maraviroc effectively reverses HIV latency by phosphorylation of Nf-kappa B
Symons, J.; vanLelyveld, S. F. L.; deSpiegelaere, W.; Wensing, A. M. J.; Zerbato, J. M.; vanHam, P. M.; Drylewicz, J.; Middel, A.; Hoepelman, A. I. M.; Cameron, P. U.; Lu, H. K.; Dantanarayana, A. I.; Borghans, J. A. M.; Vandekerckhove, L.; Lewin, S. R.; Tesselaar, K.; Nijhuis, M.
(2018) Journal of the International AIDS Society [E], volume 21, issue S6, pp. 29 - 30